Pulmonary metastasectomy for colorectal cancer: Recent reports prompt a review of the available evidence

Current Colorectal Cancer Reports

Volumn 10, Issue 3, 2014, Pages 296-302

  Treasure, Tom ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Pulmonary metastasectomy; Randomised controlled trials

Indexed keywords

EID: 84906829387     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-014-0234-5     Document Type: Article

References (58)

1. Guideline Development Group. Colorectal cancer: the diagnosis and management of colorectal cancer. London: National Institute for Health and Clinical Excellence; 2011. Available from: http://guidance.nice.org.uk/CG131/ Guidance/pdf/English. Accessed 7 Oct 2012.
2. Benson A et al. Colon cancer version 3.2014. Fort Washington: National Cancer Collaborative Network; 2014. http://www.nccn.org/professionals/physician- gls/pdf/colon.pdf.
3. Treasure T, Utley M, Hunt I. When professional opinion is not enough: surgical resection of pulmonary metastases. BMJ. 2007;334(7598):831-2.
4. Treasure T, Fallowfield L, Lees B, Farewell V. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax. 2012;67(2):185-7.
5. •• Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572-9. The authors used 15 published case series which had to include more than 40 patients, and tat were published from 2000 to 2011, to obtain pooled data on 2,925 patients. HRs for death within 5 years were 2.04 if there was more than one metastasis, 1.91 if there was an elevated prethoracotomy CEA level, 1.59 for an interval less than 3 years between the primary and secondary operations and 1.65 if there were positive hilar or mediastinal nodes.
6. •• Embun R, Fiorentino F, Treasure T, Rivas JJ, Molins L. Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open. 2013;3(5). Data were collected prospectively from March 2008 to February 2010 from 32 Spanish units estimated to capture 60% of the national practice. Of these patients, 55% had a solitary metastasis and 46% had elevated CEA level, and the median interoperative interval was 28 months. There is a comparison with the HRs reported in Gonzalez et al. [5]
7. 2 test). After interim analysis, the trialists were told that they were very unlikely to ever show a difference in overall survival as themain outcome measure so they changed it to surgical treatment with curative intent.
8. Pastorino U, BuyseM, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37-49. (Pubitemid 27034340)
9. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324-38. (Pubitemid 46921128)
10. Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol. 2010;5(6 Suppl 2):S172-8.
11. Fiorentino F, Hunt I, Teoh K, Treasure T, Utley M. Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med. 2010;103(2):60-6.
12. Simms L, Barraclough H, Govindan R. Biostatistics primer: what a clinician ought to know-prognostic and predictive factors. J Thorac Oncol. 2013;8(6):808-13.
13. Menon A, Milton R, Thorpe JA, Papagiannopoulos K. The value of video-assisted mediastinoscopy in pulmonary metastasectomy. Eur J Cardiothorac Surg. 2007;32(2):351-4. (Pubitemid 47021445)
14. Treasure T, Utley M. Statistics for the rest of us: ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg. 2007;133(6):1414-8. (Pubitemid 46805160)
15. Åberg T, Malmberg KÅ, Nilsson B, Nõu E. The effect of metastasectomy: fact or fiction? Ann Thorac Surg. 1980;30(4): 378-84. (Pubitemid 10004211)
16. Levesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087.
17. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167(4):492-9.
18. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16(3):241-9. (Pubitemid 46431687)
19. McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ. Lung resection for colorectal metastases. 10-year results. Arch Surg. 1992;127(12):1403-6.
20. Okumura S, Kondo H, Tsuboi M, Nakayama H, Asamura H, Tsuchiya R, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg. 1996;112(4):867-74. (Pubitemid 26339257)
21. Utley M, Treasure T, Linklater K, Moller H. Betterout than in? The resection of pulmonary metastases from colorectal tumours. In: Xie X, Lorca F, Marcon E, editors. Operations research for health care engineering: Proceedings of the 33rd International Conference onOperational Research Applied to Health Services. Saint-Etienne: Publications de l'Universitaire de Saint-Etienne; 2008. p. 493-500.
22. Utley M, Treasure T. Interpreting data from surgical follow-up studies: the role of modeling. J Thorac Oncol. 2010;5(6 Suppl 2): S200-2.
23. Fiorentino F, Treasure T. Pulmonary metastasectomy for colorectal cancer: making the case for a randomized controlled trial in the zone of uncertainty. J Thorac Cardiovasc Surg. 2013;146(4):748- 52.
24. Fiorentino F, Treasure T. Pulmonary metastasectomy: are observational studies sufficient evidence for effectiveness? Ann Thorac Surg. 2013;96(4):1129-31.
25. Greenberg SA.How citation distortions create unfounded authority: analysis of a citation network. BMJ. 2009;339:b2680.
26. Fiorentino F, Vasilakis C, Treasure T. Clinical reports of pulmonary metastasectomy for colorectal cancer: a citation network analysis. Br J Cancer. 2011;104(7):1085-97.
27. Blalock A. Recent advances in surgery. N Engl J Med. 1944;231: 261-7.
28. Northover J, Houghton J, Lennon T. CEA to detect recurrence of colon cancer. JAMA. 1994;272(1):31. (Pubitemid 24195440)
29. Doshi P, Dickersin K, Healy D, Vedula SS, Jefferson T. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ. 2013;346:f2865.
30. Loder E, Godlee F, Barbour V, Winker M. Restoring the integrity of the clinical trial evidence base. BMJ. 2013;346:f3601.
31. Treasure T, Monson K, Fiorentino F, Russell RCG. The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted re-operation for recurrent colorectal cancer. BMJ Open. 2014;4:e004385.
32. • Ruers T, Punt C, van CF, Pierie JP, Borel-Rinkes I, Ledermann JA, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol 2012;23(10):2619-26. This is important for two reasons. One is that it is an RCT, which distinguishes it in the literature related to resection and ablation of metastases. The second is the sentence: 'The study shows that local tumour ablation by RFA in combination with systemic therapy results in an excellent survival, which however was also achieved in the control arm,' The finding of the study was there was no difference between the groups, so any treatment effect, excellent or otherwise, cannot be attributed to RFA.
33. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8-10.
34. Treasure T. Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity? J R Soc Med. 2012;105(6):242-6.
35. Peitzman SJ. From Bright's disease to end-stage renal failure. In: Rosenberg CE, Golden J, editors. Framing disease. Philadelphia: Rutgers; 1992. p. 3-19.
36. Rettig RA. Special treatment - the story of Medicare's ESRD entitlement. N Engl J Med. 2011;364(7):596-8.
37. Grunhagen D, Jones RP, Treasure T, Vasilakis C, Poston GJ. The history of adoption of hepatic resection for metastatic colorectal cancer: 1984-95. Crit Rev Oncol Hematol. 2013;86(3):222-31.
38. Wangensteen O, Lewis F, Arhelger S, Muller J, Maclean L. An interim report upon the second look procedure for cancer of the stomach, colon, and rectum and for limited intraperitoneal carcinosis. Surg Gynecol Obstet. 1954;99(3):257-67.
39. Polk Jr HC, Spratt Jr JS. Recurrent colorectal carcinoma: detection, treatment, and other considerations. Surgery. 1971;69(1):9-23.
40. Ellis H. Is a 'second look operation' justified in suspected recurrences after abdominal cancer surgery? Br J Surg. 1975;62(10):830-2.
41. Welch JP, Donaldson GA. Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg. 1978;135(4):505-11. (Pubitemid 8336686)
42. Mach JP, Jaeger P, Bertholet MM, Ruegsegger CH, Loosli RM, Pettavel J. Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). Lancet. 1974;304(7880):535-40.
43. Mackay AM, Patel S, Carter S, Stevens U, Laurence DJ, Cooper EH, et al. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J. 1974;4(5941):382-5.
44. Staab HJ, Anderer FA, Stumpf E, Fischer R. Carcinoembryonic antigen follow-up and selection of patients for second-look operation in management of gastrointestinal carcinoma. J Surg Oncol. 1978;10(3):273-82. (Pubitemid 8349376)
45. Nicholson JR, Aust JC. Rising carcinoembryonic antigen titers in colorectal carcinoma: an indication for the second-look procedure. Dis Colon Rectum. 1978;21(3):163-4. (Pubitemid 8341908)
46. Martin Jr EW, Cooperman M, Carey LC, Minton JP. Sixty secondlook procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res. 1980;28(5):389-94. (Pubitemid 10116914)
47. Goldenberg DM. Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement. Br Med J (Clin Res Ed). 1981;282(6261):373-5. (Pubitemid 11173651)
48. Hughes ES, McConchie IH, McDermott FT, Johnson WR, Price AB. Resection of lung metastases in large bowel cancer. Br J Surg. 1982;69(7):410-2. (Pubitemid 12045420)
49. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100(2):278-84. (Pubitemid 16070861)
50. Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery. 198;103(3):278-88.
51. Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am. 1989;69(2):339-59. (Pubitemid 19092640)
52. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77(11):1241-6.
53. Scheele J, Altendorf-Hofmann A, Stangl R, Gall FP. Pulmonary resection for metastatic colon and upper rectum cancer. Is it useful? Dis Colon Rectum. 1990;33(9):745-52. (Pubitemid 20308160)
54. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110(1):13-29.
55. Rosen CB, Nagorney DM, Taswell HF, Helgeson SL, Ilstrup DM, Van Heerden JA, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216(4):493-504.
56. Lennon T, Houghton J, Northover J. Post operative CEA monitoring and second-look surgery in colorectal cancer: trial results. Br J Cancer. 1994;70(Suppl xxii):16.
57. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343(8910):1405-10. (Pubitemid 24167517)
58. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995;19(1):59 - 71.